Skip to main content Accessibility help
×
Home

Predictors of Improvement in Tardive Dyskinesia Following Discontinuation of Neuroleptic Medication

  • William M. Glazer (a1), Hal Morgenstern (a2), Nina Schooler (a3), Cathy S. Berkman (a4) and Daniel C. Moore (a5)...

Abstract

Forty-nine chronic psychiatric out-patients (ten were schizophrenic) with tardive dyskinesia (TD) were examined monthly for a mean of 40 weeks (range 1–59 months) after discontinuation of neuroleptic medication. Complete and persistent reversibility of TD was rare (2%), but many patients showed noticeable improvement in movements within the first year of discontinuation, which was sometimes interrupted by psychological relapse. Using three separate outcome measures and appropriate model-fitting techniques for each, we identified several predictors of improvement in TD, including an affective or schizoaffective psychiatric diagnosis, chronic (over 20 years) psychiatric illness, being employed, younger age, and increased neuroleptic dose before discontinuation. Consistent findings emerging from these analyses suggest that the type and history of psychiatric illness affect the course of TD.

Copyright

Corresponding author

School of Medicine, Department of Psychiatry, 34 Park Street, New Haven, Connecticut 06519, USA

References

Hide All
Carpenter, W. T. & Heinrichs, D. W. (1983) Early intervention, time-limited, targeted pharmacotherapy of schizophrenia. Schizophrenia Bulletin, 9, 533542.
Crane, G. E. (1973) Persistent dyskinesia. British Journal of Psychiatry, 122, 395405.
Crane, G. E., Ruis, P., Kernohan, W. J., et al (1969) Effects of drug withdrawal on tardive dyskinesia. Actizitas Nervosa Superior, 11, 3035.
Crow, T. J., Owens, D. G. C., Johnstone, E. C., et al (1983) Does tardive dyskinesia exist? Moderne Probleme der Pharmakopsychiatrie, 21, 206219.
Cutler, N. R., Post, R. M., Rey, A. C., et al (1981) Depression-dependent dyskinesias in two cases of manic-depressive illness. New England Journal of Medicine, 304, 10881089.
Davis, K. L., Berger, P. A. & Hollister, L. E. (1976) Tardive dyskinesia and depressive illness. Psychopharmacology Communications, 2, 125130.
Degkwitz, R. (1969) Extrapyramidal motor disorders following long-term treatment with neuroleptic drugs. In Psychotropic Drugs and Dysfunctions of the Basal Ganglia (eds G.E. Crane & R. Gardner). Washington, DC: US Public Health Service.
Edwards, H. (1970) The significance of brain damage in persistent oral dyskinesia. British Journal of Psychiatry, 116, 271275.
Endicott, J. & Spitzer, R. L. (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry, 35, 837844.
Glazer, W. M. (1986) Notes from a tardive dyskinesia clinic. Yale Psychiatric Quarterly, 8, 415.
Glazer, W. M. & Moore, D. C. (1981) A tardive dyskinesia clinic in a mental health center. Hospital and Community Psychiatry, 32, 572574.
Glazer, W. M., Moore, D. C., Schooler, N., et al (1984) Tardive dyskinesia: a discontinuation study. Archives of General Psychiatry, 41, 623627
Glazer, W. M., Moroenstern, H. & Niedzwiecki, D. (1988) Heterogeneity of tardive dyskinesia: a multivariate analysis. British Journal of Psychiatry, 152, 253259.
Granacher, R. (1981) Differential diagnosis of tardive dyskinesia: an overview. American Journal of Psychiatry, 138, 12881297.
Hambra, B. J., Nasrallah, H., Clancy, J., et al (1983) Psychiatric diagnosis and risk for tardive dyskinesia. Archives of General Psychiatry, 40, 347348.
Hershon, H. I., Kennedy, P. F. & McGuire, R. J. (1972) Persistence of extrapyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy. British Journal of Psychiatry, 120, 4150.
Hollister, L. E. (1977) Anti-psychotic medications and the treatment of schizophrenia. In Psychopharmacology: From Theory to Practice (eds J. D. Barchas, P. A. Berger, R. D. Ciaranello, et al). New York: Oxford Publishing Press.
Hunter, R., Earl, C. J. & Thornicroft, S. (1964) An apparently irreversible syndrome of abnormal movements following phenothiazine medication. Proceedings of the Royal Society of Medicine, 157, 758762.
Jeste, D., Potkin, S., Feder, S., et al (1979) Tardive dyskinesia: reversible and persistent. Archives of General Psychiatry, 36, 585590.
Kane, J., Wegner, J. T., Stenzler, S., et al (1980) The prevalence of presumed tardive dyskinesia in psychiatric inpatients and outpatients. Psychopharmacology, 69, 247251.
Kane, J., Woerner, M., Weinhold, P., et al (1984) Incidence of tardive dyskinesia: five year data from a prospective study. Psychopharmacology Bulletin, 20, 3940.
Karson, C. G., Jeste, D. V. & Bigelow, L. B. (1985) Tardive dyskinesia and psychopathology in chronic schizophrenia: a cross-sectional study. Comprehensive Psychiatry, 26, 388391.
Mukherjee, S., Rosen, D. & Cardenas, C. (1982) Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical and drug history variables. Archives of General Psychiatry, 39, 466469.
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799812.
Owens, D. G. C., Johnstone, E. C. & Frith, C. D. (1982) Spontaneous involuntary disorders of movement. Archives of General Psychiatry, 39, 452461.
Paulson, C. W. (1968) An evaluation of the permanence of the “tardive dyskinesia”. Diseases of the Nervous System, 24, 692694.
Pearlson, G. D., Garbacz, D. J., Tompkins, R. H., et al (1984) Clinical correlates of lateral ventricular enlargement in bipolar affective disorder. American Journal of Psychiatry, 141, 253256.
Pryce, I. G. & Edwards, H. (1966) Persistent oral dyskinesia in female mental hospital patients. British Journal of Psychiatry, 112, 983987.
Quitkin, F., Rifkin, A. & Gochfeld, L. (1977) Tardive dyskinesia: are first signs reversible? American Journal of Psychiatry, 134, 8487.
Rush, M., Diamond, F. & Alpert, M. (1982) Depression as a risk factor in tardive dyskinesia. Biological Psychiatry, 17, 387392.
Smith, J. M., Kucharski, L. T. & Oswald, W. T. (1979) Tardive dyskinesia: effect of age, sex and criterion level of symptomatology on prevalence estimates. Psychopharmacology Bulletin, 15, 6971.
Smith, J. M. & Baldessarini, R. J. (1980) Changes in prevalence, severity and recovery in tardive dyskinesia with age. Archives of General Psychiatry, 37, 13681373.
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry, 35, 773782.
Uhrbrand, L. & Faurbye, A. (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine, and electroconvulsive therapy. Psychopharmacologia, 1, 408418.
Yagi, G., Ogita, K., Ohtsuha, N., et al (1976) Persistent dyskinesia after long-term treatment with neuroleptics in Japan: its present status and clinical problems. Keio Journal of Medicine, 25, 2735.
Yassa, R., Nair, V. & Schwartz, G. (1984) Tardive dyskinesia and the primary psychiatric diagnosis. Psychosomatics, 25, 135138.
Yassa, R. & Schwartz, G. (1984) Depression as a predictor in the development of tardive dyskinesia. Biological Psychiatry, 19, 441444.

Predictors of Improvement in Tardive Dyskinesia Following Discontinuation of Neuroleptic Medication

  • William M. Glazer (a1), Hal Morgenstern (a2), Nina Schooler (a3), Cathy S. Berkman (a4) and Daniel C. Moore (a5)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Predictors of Improvement in Tardive Dyskinesia Following Discontinuation of Neuroleptic Medication

  • William M. Glazer (a1), Hal Morgenstern (a2), Nina Schooler (a3), Cathy S. Berkman (a4) and Daniel C. Moore (a5)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *